報價延遲最少15分鐘:2025/04/15 14:48 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
5 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
--/--
|
|
企業價值
90.12M
|
| 資產負債 |
|
每股賬面淨值
不適用
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
57.68M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/04/15 14:48 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq,Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors. |